ArticleFrontiers in immunology2026

Serum sCD163 as a potential biomarker for predicting poor functional outcome at 3 months in acute ischemic stroke without reperfusion: a prospective study.

Meijuan Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.